GENEURO SA (GNRO.PA) Stock Price, Quote, News and Overview
EPA:GNRO - Euronext Paris - Matif - CH0308403085 - Common Stock - Currency: EUR
GNRO.PA Quote, Performance and Key Statistics
EPA:GNRO (4/25/2025, 7:00:00 PM)
0.0712
+0 (+1.71%)
The current stock price of GNRO.PA is 0.0712 EUR. In the past month the price increased by 16.34%. In the past year, price decreased by -95.02%.
GNRO.PA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.11 | 285.16B | ||
| AMG.DE | AMGEN INC | 14.09 | 131.97B | ||
| GIS.DE | GILEAD SCIENCES INC | 22.32 | 112.70B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1723.6 | 110.78B | ||
| ARGX.BR | ARGENX SE | 352.5 | 32.72B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 24.54B | ||
| IDP.DE | BIOGEN INC | 7.17 | 15.20B | ||
| 0QF.DE | MODERNA INC | N/A | 9.45B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
| BIO.DE | BIOTEST AG | 24.8 | 1.68B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.54B | ||
| BIO3.DE | BIOTEST AG-VORZUGSAKTIEN | 17.54 | 1.19B |
Related stock screener links
About GNRO.PA
Company Profile
GeNeuro SA is a clinical stage company, which engages in the research and development of pharmaceutical products. The company is headquartered in Plan-Les-Ouates, Geneve and currently employs 19 full-time employees. The company went IPO on 2016-04-15. The firm's main product, GNbAC1, is a humanized monoclonal antibody that is in clinical development phase IIb. GNbAC1 neutralizes the MSRV-Env protein rather than targeting the patient's immune system, and slows down or even halts the progression of multiple sclerosis. The firm's main shareholders are Eclosion2, a launching platform for new companies in the life sciences field, bioMerieux SA, which specializes in vitro diagnostics for medical and industrial applications, Institut Merieux, a private equity company, and Servier, an independent French pharmaceutical company.
Company Info
GENEURO SA
3, Chemin du Pre-Fleuri
Plan-les-Ouates GENEVE CH
Employees: 17
Company Website: https://www.geneuro.com/
Investor Relations: http://www.geneuro.ch/en/investors/documentation-2/annual-reports
Phone: 41225524800
GENEURO SA / GNRO.PA FAQ
What is the stock price of GENEURO SA today?
The current stock price of GNRO.PA is 0.0712 EUR. The price increased by 1.71% in the last trading session.
What is the ticker symbol for GENEURO SA stock?
The exchange symbol of GENEURO SA is GNRO and it is listed on the Euronext Paris - Matif exchange.
On which exchange is GNRO.PA stock listed?
GNRO.PA stock is listed on the Euronext Paris - Matif exchange.
What is GENEURO SA worth?
GENEURO SA (GNRO.PA) has a market capitalization of 2.12M EUR. This makes GNRO.PA a Nano Cap stock.
How many employees does GENEURO SA have?
GENEURO SA (GNRO.PA) currently has 17 employees.
What are the support and resistance levels for GENEURO SA (GNRO.PA) stock?
GENEURO SA (GNRO.PA) has a support level at 0.05. Check the full technical report for a detailed analysis of GNRO.PA support and resistance levels.
Is GENEURO SA (GNRO.PA) expected to grow?
The Revenue of GENEURO SA (GNRO.PA) is expected to decline by -100% in the next year. Check the estimates tab for more information on the GNRO.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GENEURO SA (GNRO.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GNRO.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GNRO.PA, evaluating the profitability, health, valuation and growth aspects
- GENEURO SA (GNRO.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENEURO SA (GNRO.PA) Sales and EPS estimates to see what analysts future expectations are.
- GENEURO SA (GNRO.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENEURO SA (GNRO.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENEURO SA (GNRO.PA) Stock Chart to make your own analysis
- GENEURO SA (GNRO.PA) Latest news and press-releases to stay up to date.
Does GENEURO SA (GNRO.PA) stock pay dividends?
GNRO.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of GENEURO SA (GNRO.PA)?
GENEURO SA (GNRO.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.6).
GNRO.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to GNRO.PA. When comparing the yearly performance of all stocks, GNRO.PA is a bad performer in the overall market: 99.49% of all stocks are doing better.
GNRO.PA Financial Highlights
Over the last trailing twelve months GNRO.PA reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS decreased by -17.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -231.93% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GNRO.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to GNRO.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -28.12% and a revenue growth -100% for GNRO.PA